Preparation, evaluation, and in vitro cytotoxicity studies of artesunate-loaded glycyrrhetinic acid decorated PEG-PLGA nanoparticles

References

• Fu X, Wen H, Jing L, et al. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Cancer Sci. 2017;108(4):620–631.
   PubMed Web of Science ®Google Scholar
• Shen Z, Li B, Liu Y, et al. A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers–ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy. Nanomedicine. 2018;14(2):227–236.
   PubMed Web of Science ®Google Scholar
• Li L, Wang H. Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 2016;379(2):191–197.
   PubMed Web of Science ®Google Scholar
• Zhu X, Tsend-Ayush A, Yuan Z, et al. Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy. Int J Pharm. 2017;529(1–2):451–464.
   PubMedGoogle Scholar
• Park JH, Saravanakumar G, Kim K, et al. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev. 2010;62(1):28–41.
   PubMed Web of Science ®Google Scholar
• Yu JM, Li YJ, Qiu LY, et al. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization. J Pharm Pharmacol. 2009;61(6):713–719.
   PubMed Web of Science ®Google Scholar
• Mir M, Ahmed N, Rehman AU. Recent applications of PLGA based nanostructures in drug delivery. Colloids Surf B Biointerfaces. 2017;159:217–231.
   PubMed Web of Science ®Google Scholar
• Xu B, Wu GR, Zhang XY, et al. An overview of structurally modified glycyrrhetinic acid derivatives as antitumor agents. Molecules. 2017;22(6):924.
   Web of Science ®Google Scholar
• Madani F, Esnaashari SS, Mujokoro B, et al. Investigation of effective parameters on size of paclitaxel loaded PLGA nanoparticles. Adv Pharm Bull. 2018;8(1):77–84.
   PubMed Web of Science ®Google Scholar
• Babos G, Biró E, Meiczinger M, et al. Dual drug delivery of sorafenib and doxorubicin from PLGA and PEG-PLGA polymeric nanoparticles. Polymers. 2018;10(8):895.
   PubMed Web of Science ®Google Scholar
• Song X, Wang J, Xu Y, et al. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: inhibition effects enhanced and side effects reduced. Colloids Surf B Biointerfaces. 2019;180:110–117.
   PubMed Web of Science ®Google Scholar
• Riaz MK, Riaz MA, Zhang X, et al. Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. Int J Mol Sci. 2018;19(1):195.
   PubMed Web of Science ®Google Scholar
• Ghaffari M, Dehghan G, Abedi-Gaballu F, et al. Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting. Eur J Pharm Sci. 2018;122:311–330.
   PubMed Web of Science ®Google Scholar
• Sun Y, Dai C, Yin M, et al. Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes. Int J Nanomedicine. 2018;13:1621–1632.
   PubMed Web of Science ®Google Scholar
• Wu F, Li X, Jiang B, et al. Glycyrrhetinic acid functionalized nanoparticles for drug delivery to liver cancer. J Biomed Nanotechnol. 2018;14(11):1837–1852.
   PubMed Web of Science ®Google Scholar
• Hussain H, Green IR, Shamraiz U, et al. Therapeutic potential of glycyrrhetinic acids: a patent review (2010–2017). Expert Opin Ther Pat. 2018;28(5):383–398.
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu Z, Zheng Y, et al. Glycyrrhetinic acid functionalized graphene oxide for mitochondria targeting and cancer treatment in vivo. Small. 2018;14(4):1703306.
   Web of Science ®Google Scholar
• Cao M, Gao Y, Zhan M, et al. Glycyrrhizin acid and glycyrrhetinic acid modified polyethyleneimine for targeted DNA delivery to hepatocellular carcinoma. Int J Mol Sci. 2019;20(20):5074.
   Web of Science ®Google Scholar
• Singh H, Kim SJ, Kang DH, et al. Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivity. Chem Commun (Camb). 2018;54(87):12353–12356.
   PubMed Web of Science ®Google Scholar
• Li H, Xu K, Pian G, et al. Artesunate and sorafenib: combinatorial inhibition of liver cancer cell growth. Oncol Lett. 2019;18(5):4735–4743.
   PubMed Web of Science ®Google Scholar
• Yao X, Zhao CR, Yin H, et al. Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells. Acta Pharmacol Sin. 2020. [Online ahead of print].
   Google Scholar
• Ilamathi M, Santhosh S, Sivaramakrishnan V. Artesunate as an anti-cancer agent targets Stat-3 and favorably suppresses hepatocellular carcinoma. Curr Top Med Chem. 2016;16(22):2453–2463.
   PubMed Web of Science ®Google Scholar
• Chadha R, Gupta S, Pathak N. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies. Drug Dev Ind Pharm. 2012;38(12):1538–1546.
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Tran TH, Kim JO, et al. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-d,l-lactide-co-glycolide (PLGA) nanoparticles. Arch Pharm Res. 2015;38(5):716–724.
   PubMed Web of Science ®Google Scholar
• Ho HN, Laidmäe I, Kogermann K, et al. Development of electrosprayed artesunate-loaded core-shell nanoparticles. Drug Dev Ind Pharm. 2017;43(7):1134–1142.
   PubMed Web of Science ®Google Scholar
• Huang J, Bu L, Xie J, et al. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano. 2010;4(12):7151–7160.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhang J, Hou T, et al. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy. Nanoscale. 2019;11(29):13934–13946.
   PubMed Web of Science ®Google Scholar
• Na JH, Koo H, Lee S, et al. Precise targeting of liver tumor using glycol chitosan nanoparticles: mechanisms, key factors, and their implications. Mol Pharm. 2016;13(11):3700–3711.
   PubMedGoogle Scholar
• de Barros AB, Tsourkas A, Saboury B, et al. Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI Res. 2012;2(1):39.
   PubMedGoogle Scholar
• Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1–16.
   PubMed Web of Science ®Google Scholar
• Chauhan VP, Stylianopoulos T, Martin JD, et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol. 2012;7(6):383–388.
   PubMed Web of Science ®Google Scholar
• Kulkarni SA, Feng SS. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res. 2013;30(10):2512–2522.
   PubMed Web of Science ®Google Scholar
• Minamimura T, Sato H, Kasaoka S, et a1. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int J Oncol. 2000;16(6):1153–1158.
   PubMed Web of Science ®Google Scholar
• Smith JS, Xu Z, Byrnes AP. A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells. J Virol Methods. 2008;147(1):54–60.
   PubMed Web of Science ®Google Scholar
• Jiang H, Li ZP, Tian GX, et al. Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects. Int J Nanomedicine. 2019;14:1789–1804.
   PubMed Web of Science ®Google Scholar
• Tian G, Pan R, Zhang B, et al. Liver-targeted combination therapy basing on glycyrrhizic acid-modified DSPE-PEG-PEI nanoparticles for co-delivery of doxorubicin and Bcl-2 siRNA. Front Pharmacol. 2019;10:4.
   PubMed Web of Science ®Google Scholar
• Qu Y, Sun F, He F, et al. Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy. Eur J Pharm Sci. 2019;139:1050–1036.
   Web of Science ®Google Scholar